The authors reply

Affiliations

¹ Department of Internal Medicine-Nephrology, The Ohio State University, Columbus, Ohio, USA.
² Department of Internal Medicine-Nephrology, The Ohio State University, Columbus, Ohio, USA. Electronic address: Brad.Rovin@osumc.edu.

Free article

Comment

Ana Malvar et al. Kidney Int. 2020 Apr.

Free article

. 2020 Apr;97(4):807.

doi: 10.1016/j.kint.2020.01.010.

¹ Department of Internal Medicine-Nephrology, The Ohio State University, Columbus, Ohio, USA.
² Department of Internal Medicine-Nephrology, The Ohio State University, Columbus, Ohio, USA. Electronic address: Brad.Rovin@osumc.edu.

No abstract available

Comment on

Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis.
Malvar A, Alberton V, Lococo B, Ferrari M, Delgado P, Nagaraja HN, Rovin BH. Malvar A, et al. Kidney Int. 2020 Jan;97(1):156-162. doi: 10.1016/j.kint.2019.07.018. Epub 2019 Aug 20. Kidney Int. 2020. PMID: 31685314
Discontinuation of therapy in lupus nephritis.
Ponticelli C, Moroni G. Ponticelli C, et al. Kidney Int. 2020 Apr;97(4):806-807. doi: 10.1016/j.kint.2020.01.009. Kidney Int. 2020. PMID: 32200866 No abstract available.